Quantumzyme is a biotransformation company, focused on clean and green chemistry. Customer centric research to enhance enzyme activity, selectivity and specificity by applying novel quantum mechanics, molecular modelling and engineering approaches.
A clean environment ensures healthy living for our current and future generations. The more careless we are towards the environment, the more polluted it will become with toxins and hazardous chemicals which will one way or another impact all life on our planet. Quantumzyme's vision is to promote a clean, healthy and well protected environment supporting a sustainable society and economy.
Simplify Complex Chemistry
QM Enabled Biotransformation
We realize our vision by developing a focused approach to aid all chemical companies to harness the power of technology in simplifying complex chemistry, reducing the number of steps by implementing scientific rationale like Quantum Mechanics in biology. As often misquoted, Einstein's objection to God playing dice, we believe in mathematical laws of nature, respect nature's efficiency in biomolecular processes and giving our best while limited by the resource to compute all the possibilities.
Naveen comes with more than 20 years of experience covering a broad range of scientific, entrepreneurial and innovation strategies. With markets spanning Europe, USA, Australia and India, Prior to founding QuantumzymeTM, he also served as the Director at Philips Research.
Nishant comes with 17+ years of experience in financial analysis, business development, for the healthcare and pharmaceutical sector in India. Previously served as Business Controller for India’s oldest Company in the field of regenerative medicine based in Bangalore.
Dwaraka served as Associate Director of R&D at AstraZeneca India in his previous role and comes with more than 32 years in scientific, Science IT & Informatics domain. Accomplished, versatile director with a progressive, stellar career history of achievement leading complex infrastructure, risk management, and transformative initiatives within high profile corporations.
Venu comes with 23+ years of IT industry experience with strong focus on Program/Project management and Delivery management. Prior to joining Quantumzyme, Venu was with NTT DATA Services as IT Director where he managed multiple projects with focus on Healthcare Solutions, Integration Services, Web and Client Server applications, GUI applications, PCI/SOX compliance and CRM solutions.
Department of Chemical and Biochemical Engineering
Denmark Technical University, Denmark
Prof. John M. Woodley is a bioprocess engineer who has had an interest in the biological synthesis of useful chemicals, using biocatalysis and fermentation for the last 30 years. His research is at the interface of bioprocess engineering, process chemistry and reaction engineering.
It includes both theoretical and experimental work at different scales:
Department of Chemistry
IIT Kanpur
Prof. Nair’s work mainly focuses on simulating chemical reactions in condensed matter systems using ab initio or hybrid QM/MM molecular dynamics simulation techniques. Novel QM/MM techniques as well as enhanced sampling techniques are also developed in his group. His group also co-develops the CPMD program package. New atomistic force-fields are also developed to model complex systems like polymer-oxide interface, alumino-silicates, high-performance polymers, and polymer nano-composites.
Some of his recent work covers:
Department of Chemistry
Griefswald University
Prof. Matthias’s work mainly focuses on enzyme discovery and enzyme engineering for biocatalysis, with the use of in silico enzyme engineering tools. For enzyme discovery, his group uses in silico screening approaches to identify biocatalysts with desired properties and use enzyme engineering techniques to improve proteins in a desired way.
Some of his recent work covers:
Department of Chemistry
Manchester Institute of Biotechnology, U.K. England
Prof. Turner's research in general is based on biochemistry and organic chemistry, specifically on biotechnology, cell biology, biocatalysis and organic synthesis. Prof. Turner’s group combine enzyme discovery with protein engineering and directed evolution methods in order to develop biocatalysts with tailored properties including high (stereo) selectivity, improved activity and enhanced stability. These biocatalysts, which include amine/alcohol oxidases, imine reductases, lyases, transaminases and monooxygenases, are then applied to the synthesis of a range of target molecules especially pharmaceuticals and fine chemicals.
Read MoreSynthetic Chemistry, Organic Chemistry
Ex-Principal Scientist AstraZeneca
Dr. Manjunath has 39 years of experience in chemical, pharmaceutical, agrochemical and biotech industries. Expertise in various fields of organic chemistry covering the spectrum of drug design & development, process design & development and commercialization of developed technologies in Pharma/Agro/Fine chemical areas. The areas of expertise includes design of chemical Research lab, chemical plant, setting up a new research group, coaching and training young scientists in good research practices, design of good documentation systems. He has about 30 publications in leading journals and 16 patents to his credit.
Quantumzyme was incorporated on 21st September with pre-seed investment from Mr. Sunil Diwakar and Mr. Srinidhi Nagara Gadde
First year of operations witnessed successful generation of technology PoC with Prof. Uwe Bornscheuer using QZyme WorkbenchTM
Secured orders from Rossari Biotech and Advanced Enzymes Technologies
Quantumzyme successfully raised seed funding from Ajanta Pharma founder’s family office
Entered into two IP development deals, creating value for QZyme WorkbenchTM team and more customers internationally
Enhancing service capabilities from in silico contract research to providing complete biotransformation solutions with lab validated engineered enzymes
R & D pipeline for value creation through development of critical IP
Copyrights © 2023 All Rights Reserved by Quantumzyme LLP
